Brief: Tela Bio Reports First Quarter 2023 Financial Results
May 11 (Reuters) - Tela Bio Inc TELA.O :
* Q1 REVENUE ROSE 45 PERCENT TO $11.9 MILLION
* TELA BIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
* Q1 REVENUE VIEW $12.02 MILLION -- REFINITIV IBES DATA
* REAFFIRMS FULL YEAR 2023 REVENUE GUIDANCE WITH A RANGE OF
$60
MILLION TO $65 MILLION
* QTRLY LOSS PER SHARE $0.63
* Q1 EARNINGS PER SHARE VIEW $-0.56, REVENUE VIEW $12.0
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9cHv14
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants